Robert S. Kerbel
Affiliations: | University of Toronto, Toronto, ON, Canada |
Area:
Medical Biophysics, Cell BiologyGoogle:
"Robert Kerbel"Mean distance: (not calculated yet)
Children
Sign in to add traineeAndrea Frankel | grad student | 2002 | University of Toronto |
Joanne L. Yu | grad student | 2002 | University of Toronto |
Alicia M. Viloria-Petit | grad student | 2003 | University of Toronto |
Jennifer Tran | grad student | 2004 | University of Toronto |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Liu X, Chipurupalli S, Jiang P, et al. (2022) ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth. Cell Death & Disease. 13: 687 |
Huijbers EJM, Khan KA, Kerbel RS, et al. (2022) Tumors resurrect an embryonic vascular program to escape immunity. Science Immunology. 7: eabm6388 |
Khan KA, Wu FT, Cruz-Munoz W, et al. (2021) Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer. Embo Molecular Medicine. e08253 |
Khan KA, Ponce de Léon JL, Benguigui M, et al. (2020) Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer. Npj Breast Cancer. 6: 29 |
Schito L, Rey S, Xu P, et al. (2020) Metronomic chemotherapy offsets HIFα induction upon maximum-tolerated dose in metastatic cancers. Embo Molecular Medicine. e11416 |
Khan KA, Kerbel RS. (2020) A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis. Embo Molecular Medicine. e12355 |
Muñoz R, Hileeto D, Cruz-Muñoz W, et al. (2019) Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion. Plos One. 14: e0222580 |
Timaner M, Kotsofruk R, Raviv Z, et al. (2019) Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1. Oncogene |
Reguera-Nuñez E, Man S, Xu P, et al. (2019) Variable impact of three different antiangiogenic drugs alone or in combination with chemotherapy on multiple bone marrow-derived cell populations involved in angiogenesis and immunity. Angiogenesis |
Miller IS, Shiels LP, Conroy E, et al. (2019) Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents. Scientific Reports. 9: 9204 |